๐ฐ Groupa Streptococcus News
Page 2 - Groupa Streptococcus News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Groupa Streptococcus. Real-time updates on events, politics, business and more.
May 2, 2024
The University of Dundee are leading an initiative to develop the first vaccine for Strep A as part of a £2. Click to read more...
May 1, 2024
Kobe University announced on March 30th that it has discovered a molecular compound, termed
May 1, 2024
Learn about the alarming 814% increase in blood infections at University of Vermont Medical Center, potentially linked to the illicit drug xylazine.
April 30, 2024
Want to know a great way to connect with your community and generate revenue? Itโs good for themโand itโs good for you. Weโve got two resources to get you started with pharmacy-based point-of-care testing or to expand your existing program. The NCPA Innovation Center will be offering the NASPA Pharmacy-Based Point-of-Care Test and Treat National Certificate Program on May 16 in a virtual format.
April 28, 2024
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) CEO Grant Pickering sold 15,000 shares of Vaxcyte stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $61.92, for a total value of $928,800.00. Following the completion of the sale, the chief executive officer now directly owns 477,847 shares of […]
April 26, 2024
Vaxcyte (NASDAQ:PCVX – Get Free Report) and Avalon GloboCare (NASDAQ:ALBT – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability. Profitability This table compares Vaxcyte and Avalon GloboCare’s net […]
April 26, 2024
Vaxcyte (NASDAQ:PCVX – Get Free Report) and Avalon GloboCare (NASDAQ:ALBT – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability. Profitability This table compares Vaxcyte and Avalon GloboCare’s net […]
April 25, 2024
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) CFO Andrew Guggenhime sold 8,000 shares of the company’s stock in a transaction on Thursday, April 18th. The shares were sold at an average price of $61.27, for a total value of $490,160.00. Following the completion of the transaction, the chief financial officer now directly owns 95,679 shares […]
April 23, 2024
Want to know a great way to connect with your community and generate revenue? Itโs good for them โ and itโs good for you. Weโve got two resources to get you started with pharmacy-based point-of-care testing or to expand your existing program. The NCPA Innovation Center will be offering the NASPA Pharmacy-Based Point-of-Care Test and Treat National Certificate Program on May 16 in a virtual format.
April 5, 2024
Avalon GloboCare (NASDAQ:ALBT – Get Free Report) and Vaxcyte (NASDAQ:PCVX – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, profitability and valuation. Volatility & Risk Avalon GloboCare has a beta of […]